Kiniksa Pharmaceuticals (KNSA.US) was covered for the first time by Wells Fargo, giving it an increase rating, with a target price of $34.00.
Zhitong FinanceMay 3 23:51
Kiniksa Pharmaceuticals Analyst Ratings
BenzingaMay 3 23:39
Wells Fargo Initiates Coverage On Kiniksa Pharmaceuticals With Overweight Rating, Announces Price Target of $34
BenzingaMay 3 23:48
Komo: Maintaining the Kiniksa Pharmaceuticals (KNSA.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $26.00 to $30.00.
Zhitong FinanceMay 1 22:50
Kiniksa Pharmaceuticals Analyst Ratings
BenzingaMay 1 22:46
JP Morgan Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $30
BenzingaMay 1 22:47
Kiniksa Pharmaceuticals Analyst Ratings
BenzingaApr 25 01:38
Evercore ISI Group: Maintaining the Kiniksa Pharmaceuticals (KNSA.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $25.00 to $30.00.
Zhitong FinanceApr 25 01:40
Evercore ISI Group Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $30
BenzingaApr 25 01:39
Buy Rating Affirmed for Kiniksa Pharmaceuticals Amid Strong Q1 Performance and Promising Drug Prospects
TipRanksApr 24 17:44
Buy Rating Affirmed for Kiniksa Pharmaceuticals Amidst Growth Potential and Strong Commercial Execution
TipRanksApr 23 23:05
Kiniksa Pharmaceuticals (KNSA) Receives a Buy From Goldman Sachs
TipRanksApr 3 02:55
Analysts Are Bullish on These Healthcare Stocks: G1 Therapeutics (GTHX), Kiniksa Pharmaceuticals (KNSA)
TipRanksFeb 29 01:00
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Rhythm Pharmaceuticals (RYTM) and Kiniksa Pharmaceuticals (KNSA)
TipRanksJan 5 17:32
Strong Arcalyst Sales and Promising Pipeline Reinforce Kiniksa Pharmaceuticals Buy Rating
TipRanksJan 5 04:15
Kiniksa Pharmaceuticals Analyst Ratings
BenzingaJan 2 23:59
Analysts Offer Insights on Healthcare Companies: Kiniksa Pharmaceuticals (KNSA) and UnitedHealth (UNH)
TipRanksJan 2 21:20
Promising Growth and Strategic Investments Bolster Buy Rating for Kiniksa Pharmaceuticals
TipRanksNov 1, 2023 17:34
J.P. Morgan Sticks to Its Buy Rating for Kiniksa Pharmaceuticals (KNSA)
TipRanksAug 12, 2023 20:15
Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $32
BenzingaJul 26, 2023 21:39
No Data
No Data